Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chan

Showing results (1441-1450 of 1,535) with videos related to

Pageof 154
Sort By:
Genome Medicine|December 19, 2022
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escapeMahdi Golkaram, Fengshen Kuo, Sounak Gupta, et al.
JAMA|April 10, 2019
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical TrialKimmie Ng, Halla S Nimeiri, Nadine J McCleary, et al.
Nature Chemical Biology|May 26, 2025
Tegavivint triggers TECR-dependent nonapoptotic cancer cell deathLogan Leak, Ziwei Wang, Alby J Joseph, et al.
Nature Genetics|January 5, 2021
The association between tumor mutational burden and prognosis is dependent on treatment contextCristina Valero, Mark Lee, Douglas Hoen, et al.
Nature|September 17, 2008
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activityRon Firestein, Adam J Bass, So Young Kim, et al.
Cancer Research Communications|May 8, 2026
Novel Mechanism of and Therapeutic Approach for Anthracycline-Induced Cardiotoxicity (AIC)Qingzhu Wang, Wanying Zhang, Josephine Chen, et al.
Nature|February 1, 2023
Single-cell spatial immune landscapes of primary and metastatic brain tumoursElham Karimi, Miranda W Yu, Sarah M Maritan, et al.
Nature Cancer|April 9, 2021
Mutations in <i>BRCA1</i> and <i>BRCA2</i> differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapyRobert M Samstein, Chirag Krishna, Xiaoxiao Ma, et al.
EMBO Molecular Medicine|April 9, 2025
Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframeGeorgina D Barnabas, Tariq A Bhat, Verena Goebeler, et al.
Science (New York, N.Y.)|December 14, 2019
Pervasive human-driven decline of life on Earth points to the need for transformative changeSandra Díaz, Josef Settele, Eduardo S Brondízio, et al.
Pageof 154

Showing results (1441-1450 of 1,535) with videos related to

Sort By:
Pageof 154
Genome Medicine|December 19, 2022
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escapeMahdi Golkaram, Fengshen Kuo, Sounak Gupta, et al.
JAMA|April 10, 2019
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical TrialKimmie Ng, Halla S Nimeiri, Nadine J McCleary, et al.
Nature Chemical Biology|May 26, 2025
Tegavivint triggers TECR-dependent nonapoptotic cancer cell deathLogan Leak, Ziwei Wang, Alby J Joseph, et al.
Nature Genetics|January 5, 2021
The association between tumor mutational burden and prognosis is dependent on treatment contextCristina Valero, Mark Lee, Douglas Hoen, et al.
Nature|September 17, 2008
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activityRon Firestein, Adam J Bass, So Young Kim, et al.
Cancer Research Communications|May 8, 2026
Novel Mechanism of and Therapeutic Approach for Anthracycline-Induced Cardiotoxicity (AIC)Qingzhu Wang, Wanying Zhang, Josephine Chen, et al.
Nature|February 1, 2023
Single-cell spatial immune landscapes of primary and metastatic brain tumoursElham Karimi, Miranda W Yu, Sarah M Maritan, et al.
Nature Cancer|April 9, 2021
Mutations in <i>BRCA1</i> and <i>BRCA2</i> differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapyRobert M Samstein, Chirag Krishna, Xiaoxiao Ma, et al.
EMBO Molecular Medicine|April 9, 2025
Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframeGeorgina D Barnabas, Tariq A Bhat, Verena Goebeler, et al.
Science (New York, N.Y.)|December 14, 2019
Pervasive human-driven decline of life on Earth points to the need for transformative changeSandra Díaz, Josef Settele, Eduardo S Brondízio, et al.
Pageof 154